logo

HAEMONETIC(NYSE:HAE)
Haemonetics is a global company engaged in the design, manufacture and worldwide marketing of automated blood processing systems. These systems address important medical markets: surgical blood salvage, blood component collections and plasma collections. The majority of their business is outside the US.
# Employees: 2016
Address: 400 Wood Road,Braintree,MA,USA
Phone: 781 848-7100
Fax: 781-848-5106
Website: www.haemonetics.com
Email: fallon@haemonetics.com
Sector: Medical
Industry: MED PRODUCTS
Executive Officers
Brad Nutter (Chmn.; C.E.O.)
Susan M. Hanlon (V.P.; Contrl.; Princ. Acctg. Off.)
Christopher Lindop (C.F.O.; V.P.)
Susan Bartlett foote (Dir.)
Ronald Gelbman (Dir.,)
Dividend
Ex-Dividend Date: N/A
Annual Dividend: N/A
Current Dividend Yield: N/A
Dividend Paid (3 months): N/A
Indicated Dividend: N/A
Earnings
Last Earnings Date: 9/30/2009
Next Earnings Date(Expected): 2/8/2010
Mean EPS (Next Qtr): $0.72
Mean EPS (Year): $2.82
Mean Estimate(Long Term): $14.00
P/E Ratio(Based on EPS estimate): 19.180
Number of Estimates: 10
Shares Performance
Period HAE Compare to S&P
YTD -4.28 % -20.79 %
4 Weeks 5.01 % -0.31 %
12 Weeks 0.00 % -6.88 %
Shares Information
Analyst Coverage: Y
Avg Volume: 214770
Shares Outstanding: 25M
Market Cap: $1.39B
52 Week High: $64.65
52 Week Low: $48.85
P/E Ratio: 20.330
PEG Ratio: 1.370
Split: On 1/11/1993 HAE split by factor of 2.000
Earnings Performance
EPS Growth in Last Quarter: 0.00 %
EPS Growth in Last Year: 18.97 %
Sales Growth in Last Quarter: 1.94 %
Sales Growth in Last Quarter: 7.64 %
Financials
Qtr Book Value: $2.40
Cash Flow/Share: $14.36
Change in Payout Ratio: 0.000
Price/Sales: 2.240
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia